Benefit and Application of β-blocker Therapy for Patients with AMI in the Era of PCI
10.16753/j.cnki.1008-2344.2016.03.023
- VernacularTitle:P CI时代急性心肌梗死患者接受β受体阻滞剂治疗的获益与应用策略
- Author:
Chuntian WANG
1
;
Yongsheng? KE
Author Information
1. 皖南医学院弋矶山医院心内科
- Keywords:
acute myocardial infarction;
β-blockers;
percutaneous coronary intervention
- From:
Journal of Shenyang Medical College
2016;18(3):198-201
- CountryChina
- Language:Chinese
-
Abstract:
[ Abstrct] Back in the 1980s, β?blockers was widely used because of decreased myocardial infarction mortality and protected heart function. In recent years, with the rapid development of percutaneous coronary intervention ( PCI) technology, the mortality of pa?tients with acute myocardial infarction ( AMI) significantly decreased. The issue of whether patients with AMI continue to benefit fromβ?blockers treatment is disputed. This review is aim to retrospect the researches about the effects ofβ?blockers on patients with AMI in aspects of myocardial infarct size, heart failure and mortality after AMI, meanwhile summarizing the rational use ofβ?blocker therapy in the PCI era.
